Effects of Single α-to-β Residue Replacements on Recognition of an Extended Segment in a Viral Fusion Protein.
HPIV3
entry inhibitor
fusion glycoprotein
viral entry
α/β-peptide
β-amino acid
Journal
ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580
Informations de publication
Date de publication:
14 08 2020
14 08 2020
Historique:
pubmed:
22
7
2020
medline:
24
6
2021
entrez:
22
7
2020
Statut:
ppublish
Résumé
Partial replacement of α-amino acid residues with β-amino acid residues has been established as a strategy for preserving target-engagement by helix-forming polypeptides while altering other properties. The impact of β-residue incorporation within polypeptides that adopt less regular conformations, however, has received less attention. The C-terminal heptad repeat (HRC) domains of fusion glycoproteins from pathogenic paramyxoviruses contain a segment that must adopt an extended conformation in order to coassemble with the N-terminal heptad repeat (HRN) domain in the postfusion state and drive a merger of the viral envelope with a target cell membrane. Here, we examine the impact of single α-to-β substitutions within this extended N-terminal segment of an engineered HRC peptide designated VIQKI. Stabilities of hexameric coassemblies formed with the native human parainfluenza virus 3 (HPIV3) HRN have been evaluated, the structures of five coassemblies have been determined, and antiviral efficacies have been measured. Many sites within the extended segment show functional tolerance of α-to-β substitution. These results offer a basis for future development of paramyxovirus infection inhibitors with novel biological activity profiles, possibly including resistance to proteolysis.
Identifiants
pubmed: 32692914
doi: 10.1021/acsinfecdis.0c00385
pmc: PMC8019249
mid: NIHMS1676307
doi:
Substances chimiques
Antiviral Agents
0
Peptides
0
Viral Fusion Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2017-2022Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM061238
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114736
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008349
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121349
Pays : United States
Organisme : NIGMS NIH HHS
ID : F32 GM122263
Pays : United States
Références
Nat Commun. 2014;5:3067
pubmed: 24473083
Nature. 1989 Nov 16;342(6247):296-9
pubmed: 2812029
J Pediatr. 2009 May;154(5):694-9
pubmed: 19159905
Sci Adv. 2019 Apr 10;5(4):eaav4580
pubmed: 30989115
Nat Biotechnol. 2014 Jul;32(7):653-5
pubmed: 24929976
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
J Am Chem Soc. 2011 Jul 6;133(26):10038-41
pubmed: 21644542
J Am Chem Soc. 2012 Jan 11;134(1):315-23
pubmed: 22040025
Nat Chem. 2013 Mar;5(3):161-73
pubmed: 23422557
J Immunol. 2005 Sep 15;175(6):3810-8
pubmed: 16148127
J Am Chem Soc. 2020 Feb 5;142(5):2140-2144
pubmed: 31951396
Nat Chem Biol. 2007 May;3(5):252-62
pubmed: 17438550
Org Biomol Chem. 2018 Oct 31;16(42):7878-7882
pubmed: 30306175
ACS Chem Biol. 2015 Jul 17;10(7):1667-75
pubmed: 25946900
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4552-7
pubmed: 25825775
J Biol Chem. 2001 Jul 6;276(27):24525-30
pubmed: 11342555
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
Annu Rev Virol. 2014 Nov;1(1):171-89
pubmed: 26958720
Adv Drug Deliv Rev. 2017 Dec 1;122:2-19
pubmed: 27916504
J Immunol. 2019 Sep 15;203(6):1619-1628
pubmed: 31391235
J Am Chem Soc. 2006 Jul 19;128(28):9248-56
pubmed: 16834399
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14751-6
pubmed: 19706443
mBio. 2020 Feb 11;11(1):
pubmed: 32047132
Angew Chem Int Ed Engl. 2015 Mar 2;54(10):2960-5
pubmed: 25651514
Virology. 2005 May 10;335(2):276-85
pubmed: 15840526
J Am Chem Soc. 2012 May 2;134(17):7317-20
pubmed: 22524614
Curr Opin Chem Biol. 2008 Dec;12(6):692-7
pubmed: 18793750
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707
pubmed: 28720325
J Med Chem. 2018 Feb 22;61(4):1382-1414
pubmed: 28737935
J Am Chem Soc. 2014 Sep 17;136(37):12848-51
pubmed: 25191938
Chem Commun (Camb). 2019 Dec 5;55(98):14809-14812
pubmed: 31763628
Org Lett. 2015 Jul 17;17(14):3524-7
pubmed: 26153619
Chembiochem. 2013 Sep 2;14(13):1564-72
pubmed: 23929624
J Neurosci. 2015 Dec 16;35(50):16463-78
pubmed: 26674871
Nat Struct Mol Biol. 2008 Jul;15(7):690-8
pubmed: 18596815
Viruses. 2012 Apr;4(4):613-36
pubmed: 22590688
J Am Chem Soc. 2002 May 8;124(18):4972-3
pubmed: 11982357
J Am Chem Soc. 2019 Aug 14;141(32):12648-12656
pubmed: 31268705
J Med Chem. 2000 Oct 5;43(20):3803-8
pubmed: 11020297
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93
pubmed: 15964978